Patient Advocacy: an Overlooked Strategy for Achieving Equitable Market Success?
Published: | Updated:
Ellen Coleman outlines the highlights of a recent webinar on ensuring that patient advocacy is a key element of a market access strategy.
Ellen Coleman
Advertisement
Ellen Coleman (ecoleman@mkanda.com) is President and Chief Executive Officer, MK&A.
Articles by Ellen Coleman
Advertisement
Latest Updated Articles
- Patient Advocacy: an Overlooked Strategy for Achieving Equitable Market Success?
Published: May 14th 2018 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
5